During the past decade, Vseobecna fakultni nemocnice v Praze conducted 201 clinical trials. In the 10-year time frame, 201 clinical trials started and 100 clinical trials were completed, i.e. on average, 49.8% percent of trials that started reached the finish line to date. In the past 5 years, 100 clinical trials started and 66 clinical trials were completed. i.e. 66% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vseobecna fakultni nemocnice v Praze" #1 sponsor was "Pfizer" with 20 trials, followed by "Celgene" with 16 trials sponsored, "Bayer" with 15 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored and "Charles University, Czech Republic" with 15 trials sponsored. Other sponsors include 214 different institutions and companies that sponsored additional 138 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vseobecna fakultni nemocnice v Praze" #1 collaborator was "General University Hospital, Prague" with 10 trials as a collaborator, "Eli Lilly and Company" with 7 trials as a collaborator, "Charles University, Czech Republic" with 5 trials as a collaborator, "Gynecologic Oncology Group" with 4 trials as a collaborator and "Tomas Bata Hospital, Czech Republic" with 4 trials as a collaborator. Other collaborators include 197 different institutions and companies that were collaborators in the rest 185 trials.

According to Clinical.Site data, the most researched conditions in "Vseobecna fakultni nemocnice v Praze" are "Multiple Myeloma" (18 trials), "Multiple Sclerosis" (9 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Heart Failure" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Vseobecna fakultni nemocnice v Praze" in a lesser frequency.

Most popular intervention types in "Vseobecna fakultni nemocnice v Praze" are "Drug" (233 trials), "Other" (30 trials), "Biological" (22 trials), "Device" (19 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (84 trials), "Dexamethasone" (17 trials), "Lenalidomide" (11 trials), "Rituximab" (11 trials) and "Bortezomib" (10 trials). Other intervention names were less common.

The vast majority of trials in "Vseobecna fakultni nemocnice v Praze" are 263 trials for "All" genders, 26 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Vseobecna fakultni nemocnice v Praze". undefined are not yet recruiting, 66 are recruiting, 46 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 137 completed trials in Vseobecna fakultni nemocnice v Praze, undefined suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Vseobecna fakultni nemocnice v Praze, 17 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 155 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 20 trials that are defined as “Not Applicable".

Vseobecna fakultni nemocnice v Praze has several departments that took part in Clinical trials: "Vseobecna fakultni nemocnice v Praze - I. interni klinika - klinika hematologie" - 11 trials, "Fakultni Poliklinika Vseobecne Fakultni Niemocnice; Onkologicka Klinika" - 11 trials, "General University Hospital II.department of Internal Medicine-cardiology and angiology" - 5 trials, "Vseobecna fakultni nemocnice v Praze - Dept of Neurologicka klinika 1.LF UK a VFN v Praze" - 4 trials, "I Interni klinika; Vseobecna fakultni nemocnice" - 4 trials, "Onkologicka Klinka A Onkologicka Lab" - 3 trials, "Dermatovenerologicka klinika VFN a 1. LF UK" - 2 trials, "General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology" - 2 trials, "General Teaching Hospital Prague; Ophthalmology clinic" - 2 trials